NR606 Week 6 Exam V2 | NR606 Diagnosis
& Management in Psychiatric-Mental
Health II Practicum | Q&A with Rationale
(NR606 Week 6 Exam) | Chamberlain
University
1. A 9-year-old child is being evaluated for ADHD. The PMHNP understands that according to
DSM-5-TR criteria, symptoms must be present in at least how many settings?
A. Two or more settings (e.g., home and school)
B. One setting (e.g., only at home)
C. Three settings (home, school, and social activities)
D. Settings are not a requirement for diagnosis
Answer: A
Rationale: The DSM-5-TR requires that several inattentive or hyperactive-impulsive
symptoms are present in two or more settings. This ensures that the behavior is not merely
a reaction to a specific environment or individual. Accurate diagnosis depends on gathering
data from both parents and teachers to confirm cross-situational impairment.
2. When treating an adolescent with Major Depressive Disorder (MDD), which medication is
the only FDA-approved SSRI for children aged 8 and older?
A. Fluoxetine (Prozac)
,B. Escitalopram (Lexapro)
C. Sertraline (Zoloft)
D. Paroxetine (Paxil)
Answer: A
Rationale: Fluoxetine is the only SSRI with FDA approval for the treatment of depression
in children aged 8 and older. While other SSRIs may be used off-label, clinicians must be
aware of the specific indications and black box warnings. Monitoring for suicidal ideation is
mandatory during the initial phases of treatment in this population.
3. Which therapeutic approach is considered the ‘gold standard’ for treating pediatric Anxiety
Disorders and involves gradual exposure to feared stimuli?
A. Dialectical Behavior Therapy (DBT)
B. Psychoanalytic Play Therapy
C. Cognitive Behavioral Therapy (CBT)
D. Interpersonal Therapy (IPT)
Answer: C
Rationale: Cognitive Behavioral Therapy (CBT), particularly with exposure and response
prevention, is highly effective for pediatric anxiety. It focuses on identifying maladaptive
thought patterns and systematically facing fears to reduce avoidance behaviors. Research
, consistently supports CBT as a primary non-pharmacological intervention for childhood
phobias and generalized anxiety.
4. A 5-year-old child presents with persistent deficits in social communication and social
interaction across multiple contexts. What is the most likely diagnosis?
A. Social Communication Disorder
B. Autism Spectrum Disorder (ASD)
C. Intellectual Disability
D. Reactive Attachment Disorder
Answer: B
Rationale: Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social
communication and interaction, alongside restricted, repetitive patterns of behavior. These
symptoms must be present in early development and cause significant impairment in
functioning. Early intervention and comprehensive assessment are critical for optimizing
developmental outcomes in these children.
5. In the pharmacological management of ADHD, which of the following is a non-stimulant
medication that acts as a selective norepinephrine reuptake inhibitor?
A. Atomoxetine (Strattera)
B. Lisdexamfetamine (Vyvanse)
C. Methylphenidate (Ritalin)
& Management in Psychiatric-Mental
Health II Practicum | Q&A with Rationale
(NR606 Week 6 Exam) | Chamberlain
University
1. A 9-year-old child is being evaluated for ADHD. The PMHNP understands that according to
DSM-5-TR criteria, symptoms must be present in at least how many settings?
A. Two or more settings (e.g., home and school)
B. One setting (e.g., only at home)
C. Three settings (home, school, and social activities)
D. Settings are not a requirement for diagnosis
Answer: A
Rationale: The DSM-5-TR requires that several inattentive or hyperactive-impulsive
symptoms are present in two or more settings. This ensures that the behavior is not merely
a reaction to a specific environment or individual. Accurate diagnosis depends on gathering
data from both parents and teachers to confirm cross-situational impairment.
2. When treating an adolescent with Major Depressive Disorder (MDD), which medication is
the only FDA-approved SSRI for children aged 8 and older?
A. Fluoxetine (Prozac)
,B. Escitalopram (Lexapro)
C. Sertraline (Zoloft)
D. Paroxetine (Paxil)
Answer: A
Rationale: Fluoxetine is the only SSRI with FDA approval for the treatment of depression
in children aged 8 and older. While other SSRIs may be used off-label, clinicians must be
aware of the specific indications and black box warnings. Monitoring for suicidal ideation is
mandatory during the initial phases of treatment in this population.
3. Which therapeutic approach is considered the ‘gold standard’ for treating pediatric Anxiety
Disorders and involves gradual exposure to feared stimuli?
A. Dialectical Behavior Therapy (DBT)
B. Psychoanalytic Play Therapy
C. Cognitive Behavioral Therapy (CBT)
D. Interpersonal Therapy (IPT)
Answer: C
Rationale: Cognitive Behavioral Therapy (CBT), particularly with exposure and response
prevention, is highly effective for pediatric anxiety. It focuses on identifying maladaptive
thought patterns and systematically facing fears to reduce avoidance behaviors. Research
, consistently supports CBT as a primary non-pharmacological intervention for childhood
phobias and generalized anxiety.
4. A 5-year-old child presents with persistent deficits in social communication and social
interaction across multiple contexts. What is the most likely diagnosis?
A. Social Communication Disorder
B. Autism Spectrum Disorder (ASD)
C. Intellectual Disability
D. Reactive Attachment Disorder
Answer: B
Rationale: Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social
communication and interaction, alongside restricted, repetitive patterns of behavior. These
symptoms must be present in early development and cause significant impairment in
functioning. Early intervention and comprehensive assessment are critical for optimizing
developmental outcomes in these children.
5. In the pharmacological management of ADHD, which of the following is a non-stimulant
medication that acts as a selective norepinephrine reuptake inhibitor?
A. Atomoxetine (Strattera)
B. Lisdexamfetamine (Vyvanse)
C. Methylphenidate (Ritalin)
